[A case of systemic sclerosis]

Abstract

In systemic sclerosis, the presence of an anti-RNA polymerase III antibody (ARNpol3) is associated with an increased risk of cancer. The characteristic picture of this serotype includes severe diffuse cutaneous involvement, a high risk of renal scleroderma crisis and a 10 year survival of only around 30%. Pulmonary involvement is less common. We report the case of a woman initially treated for drug-induced acute interstitial lung disease revealing chronic interstitial pneumonia with autoimmune features. The disease evolved in three stages with the occurrence of a rapidly progressive diffuse skin sclerosis with anti-ARNPol3 antibodies in the context of ovarian cancer remission.

Keywords: Anti-ARNpol3 antibodies; Anticorps anti-ARNpol3; Cancer; Flecainide; Flecaïnide; Interstitial lung disease; Pneumopathie interstitielle diffuse; Sclérodermie systémique; Systemic sclerosis.